Ignite Creation Date:
2025-12-24 @ 6:52 PM
Ignite Modification Date:
2026-02-28 @ 10:51 PM
Study NCT ID:
NCT02528357
Status:
COMPLETED
Last Update Posted:
2021-05-18
First Post:
2015-08-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-11
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04-29
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-17
First Submit QC Date:
None
Study First Post Date:
2015-08-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-04-26
Results First Submit QC Date:
None
Results First Post Date:
2021-05-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-26
Last Update Post Date:
2021-05-18
Last Update Post Date Type:
ACTUAL